Paxlovid

Paxlovid, Pfizer's anti-viral medication to treat the coronavirus disease (COVID-19), is displayed in this picture illustration taken October 7, 2022.Wolfgang Rattay | ReutersThe National…

The benefit of nirmatrelvir-ritonavir (Paxlovid) for high-risk COVID-19…

Enrollment into a small trial of nirmatrelvir/ritonavir (Paxlovid) for long…

Robert M. Kaplan, MA,…

By MATTHEW PERRONE - AP Health Writer WASHINGTON (AP) — Pfizer received full approval on Thursday for its COVID-19 pill Paxlovid that's been…

Physician’s Briefing Staff THURSDAY, May 25, 2023 (HealthDay News) -- Americans with COVID-19 have been taking Paxlovid (nirmatrelvir tablets…

The Food and Drug Administration on Thursday granted full approval to Pfizer's Covid antiviral pill, Paxlovid, for adults who are at high risk of getting severely sick with the…

A prescription for Pfizers Paxlovid tablets outside of his apartment in Philadelphia, Pennsylvania on April 25, 2022. (Photo by Rachel Wisniewski/For the Washington Post)Rachel Wisniewski |…

The COVID-19 pandemic has killed nearly 7 million people worldwide (1.1 million in the United States) and severely harmed many millions more, though vaccines and antiviral treatments…

Use of nirmatrelvir-ritonavir (Paxlovid) in older adults with risk factors for severe…